Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice
British Journal of Clinical Pharmacology · 2023
DOI: 10.1111/bcp.15780 ↗Kurz gefasst
Kommentar in der Zeitschrift British Journal of Clinical Pharmacology, 2023. Verfasst von Emanuel Raschi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
disproportionality analysis, drug-drug interactions, pharmacovigilance, SGLT2 inhibitors, spontaneous reporting system, statins Drug-drug interactions (DDIs) represent an important cause of serious adverse drug reactions: this results from various guidelines promoting upfront combined pharmacological approaches and relevant polypharmacy with increasing age.The cardiovascular area, including diabetes, represents an ideal setting to characterize clinically relevant DDIs, since patients with diabetes suffer from comorbidities and are exposed to relevant chronic combination regimens, including lipidlowering drugs (statins), agents for heart failure, myocardial infarction and hypertension.Since DDIs are unlikely to be fully and formally assessed during drug development, the post-marketing phase is pivotal for their timely detection, and pharmacovigilance, through the analysis of spontaneous reporting systems (SRSs) and healthcare databases, might fill this gap.[1][2][3] The use of SRSs to detect clinically relevant DDIs was first tested on a limited number of case studies, 4,5 and then extended to a larger scale without an a priori hypothesis.2,6 Different approaches have been explored and validated in the recent past, including the Ω
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
ORCID-Profile: Emanuel Raschi
Zitieren
APA
Raschi, E., Poluzzi, E., & De Ponti, F. (2023). Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15780
Vancouver
Raschi E, Poluzzi E, De Ponti F. Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15780
BibTeX
@article{Raschi2023,
author = {Raschi, Emanuel and Poluzzi, Elisabetta and De Ponti, Fabrizio},
title = {Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
doi = {10.1111/bcp.15780}
}
EUVIMED